This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective

Volume: 22, Issue: 23, Pages: 12870 - 12870
Published: Nov 28, 2021
Abstract
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disease caused by deficient activity of acid sphingomyelinase (ASM) enzyme, leading to the accumulation of varying degrees of sphingomyelin. Lipid storage leads to foam cell infiltration in tissues, and clinical features including hepatosplenomegaly, pulmonary insufficiency and in some cases central nervous system involvement. ASM enzyme replacement therapy is currently in clinical...
Paper Details
Title
Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective
Published Date
Nov 28, 2021
Volume
22
Issue
23
Pages
12870 - 12870
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.